Epsilon M&A Deal Report - Oury Medical Group (Établissements Oury-Guyé et Fils)

Transaction Multiples for the Valuation of Private Companies

Private Group led by Tag Partners > Oury Medical Group (Établissements Oury-Guyé et Fils)

Announced Date : 31 March 2026

Type : LBO (Leverage Buy Out) ,Exit

Deal Value : Yes

Acquirer : Private Group led by Tag Partners

Target: Oury Medical Group (Établissements Oury-Guyé et Fils)

Target Country: France

Sector of activity : Health, Pharmaceuticals & Biotechnology

Business Description :

> Established in 2022, Oury Medical is an industrial group specialising in the design and manufac ...

No EMAT : 125479

Transaction multiples available

	EV/Sales	EV/Gross Profit	EV/EBITDA	EV/EBIT	Eq/PBT	P/E	Price to Book
Historic
Current

: Multiple available

n.s : Multiple calculated, but not significant

Rating *

Source: Epsilon Research / EMAT

Comparable Transactions

Number of EMAT Reports : (Health, Pharmaceuticals & Biotechnology) = 1274

Example of comparable transactions on EMAT (same sub-sector):

Date	Acquirer	Target	Country	Multiples	See details
12/06/2025	Crédit Agricole Finance et Territoires	Petits-fils	France	***
12/03/2025	Ambea	Validia Asuminen Oy	Finland	***

Source: Epsilon Research / EMAT

View Report

This report is accessible on EMAT, the reference database for private company acquisition multiples

Example of EMAT Report : click here

View Complete Report

About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

Sectors covered by our analysts

Studies & indices published by Epsilon Research Register to receive (free) publications updates

EMAT Report

Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).

Subscribe to EMAT database